- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fusion Antibodies PLC (FAB)
Fusion Antibodies PLC stock price live, this page displays LON FAB stock exchange data. View the FAB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Fusion Antibodies PLC real time stock price chart below.
What Is the Fusion Antibodies PLC Stock Price Today?
The Fusion Antibodies PLC stock price today is 12.50.
What Is the Stock Symbol for Fusion Antibodies PLC?
The stock symbol for Fusion Antibodies PLC is "FAB."
What Stock Exchange Does Fusion Antibodies PLC Trade On?
Fusion Antibodies PLC is listed and trades on the London stock exchange.
Is Fusion Antibodies PLC a Good Stock to Buy?
Determining whether Fusion Antibodies PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FAB quote. (ISIN: GB00BDQZGK16)
What Is the Fusion Antibodies PLC Stock Price Today?
The Fusion Antibodies PLC stock price today is 12.50.
What Is the Stock Symbol for Fusion Antibodies PLC?
The stock symbol for Fusion Antibodies PLC is "FAB."
What Stock Exchange Does Fusion Antibodies PLC Trade On?
Fusion Antibodies PLC is listed and trades on the London stock exchange.
Is Fusion Antibodies PLC a Good Stock to Buy?
Determining whether Fusion Antibodies PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FAB quote. (ISIN: GB00BDQZGK16)
12.50
+2.00(+19.05%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.90
13.60
52 wk Range
9.50
21.00
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.9013.60
52 wk Range
9.5021.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
FAB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Operates with a moderate level of debt
Fusion Antibodies receives patent approval in Japan- Investing.com
- Fusion Antibodies receives patent approval in Japan
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Earnings
Latest Release
Nov 24, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
838K / --
Compare FAB to Peers and Sector
Metrics to compare | FAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFABPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.0x | −4.2x | −0.4x | |
PEG Ratio | −0.35 | −0.04 | 0.00 | |
Price/Book | 18.1x | 3.1x | 2.6x | |
Price / LTM Sales | 8.2x | 6.1x | 3.1x | |
Upside (Analyst Target) | - | 181.8% | 47.0% | |
Fair Value Upside | Unlock | 0.4% | 5.6% | Unlock |
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, veterinary, diagnostic, and life science research companies. The company has a collaboration agreement with the National Cancer Institute for the use of OptiMAL. Fusion Antibodies plc was incorporated in 2000 and is based in Belfast, the United Kingdom.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Fusion Antibodies (FAB) Stock Price Today?
The Fusion Antibodies stock price today is 12.50 GBP.
What Stock Exchange Does Fusion Antibodies Trade On?
Fusion Antibodies is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Fusion Antibodies?
The stock symbol for Fusion Antibodies is "FAB."
What Is the Fusion Antibodies Market Cap?
As of today, Fusion Antibodies market cap is 13.14M GBP.
What Is Fusion Antibodies's Earnings Per Share (TTM)?
The Fusion Antibodies EPS (TTM) is -0.01.
When Is the Next Fusion Antibodies Earnings Date?
Fusion Antibodies will release its next earnings report on Sep 03, 2026.
From a Technical Analysis Perspective, Is FAB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Fusion Antibodies Stock Split?
Fusion Antibodies has split 0 times.
How Many Employees Does Fusion Antibodies Have?
Fusion Antibodies has 24 employees.
What is the current trading status of Fusion Antibodies (FAB)?
As of Aug 28, 2026, Fusion Antibodies (FAB) is trading at a price of 12.50 GBP, with a previous close of 10.50 GBP. The stock has fluctuated within a day range of 10.90 GBP to 13.60 GBP, while its 52-week range spans from 9.50 GBP to 21.00 GBP.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.